Zydus Gets USFDA Nod For Ankleshwar API Unit

Zydus Lifesciences Ltd. on Wednesday said it has received an establishment inspection report from the US Food and Drug Administration for its API manufacturing facility in Ankleshwar, Gujarat.

The US regulator conducted the inspection between March 10 and March 14 and classified the outcome as 'no action indicated', meaning no further regulatory follow-up is required, the company said in a filing. The inspection is now closed, it added.